Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity

Journal article

Open access

Peer reviewed

Expert opinion on drug safety, Vol.18(7), pp.549-552

07/03/2019

PMID: 31092063

Abstract

Bupropion

contrave

naltrexone

obesity

opioid resistant analgesia

psoriasis

url

https://doi.org/10.1080/14740338.2019.1618268View

Version of Record (VoR) Open

7 Record Views

Title: Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity
Creators: Nicholas T Bello - New Jersey Institute for Food, Nutrition, and Health, Rutgers, The State University of New Jersey
Publication Details: Expert opinion on drug safety, Vol.18(7), pp.549-552
Date published: 07/03/2019
Publisher: Taylor & Francis
Grant note: not funded
Academic Unit: Animal Sciences (SEBS)
Language: English
Resource Type: Journal article
Identifiers: 991031666135204646